July 2018

Rapid molecular methods in clinical microbiology

Microbiologist Mark Wilks highlights the potential rapid molecular methods presented in the recent conference of the British Society for Microbial Technology.

Fast molecular diagnostics for tight turnaround times

Turnaround times for diagnostic tests can be an obstacle to effectively controlling healthcare associated infections (HAI), such as methicillin-resistant Staphylococcus aureus (MRSA) and carbapenemase producing Enterobacteriaceae (CPE), with delayed results leading to ward closures and cancelled operations.

Biomedical Science Day 2018

Biomedical Science Day takes place on July 19 and the IBMS is calling on its members to join this celebration of the profession #AtTheHeartOfHealthcare, and the incredible hard work and dedication of biomedical scientists.

Clinical chemistry classics: tumour markers

This short series continues with a brief review of pioneering work in the development and clinical application of two important tumour markers – serum alpha fetoprotein and urine and serum human chorionic gonadotropin.

The progress of histopathology reporting

Jo Horne, Andrew Usher and Gerry van Schalkwyk discuss the progress of the histopathology reporting programme and look to the future.

The new dawn of immunotherapy

Steven Rosenberg made headlines around the globe for a breakthrough that could make immunotherapy a frontline cancer treatment.

The Big Question: "Does healthcare really need a 24/7 pathology service?"

Does healthcare really need a 24/7 pathology service?

How to...#communicate through social media

After creating videos to highlight pathology’s role in patient care, Claire Kennedy and Rachel Berkoff explain why they used social media to communicate their messages, and offer tips and advice on how to make the most of the medium.

Laboratory industry trade show

The Lab Innovations trade show returns to the NEC, Birmingham, on 31 October and 1 November 2018.

Diagnostics range launch

Horiba Medical UK has announced a significant development of its in vitro diagnostics product offering with the launch of its new Yumizen G range of instruments and reagents.

Top